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Abstract 
Policy makers spend large amounts of public resources on the foundation of science parks 
and other forms of geographically clustered business activities, in order to stimulate regional 
innovation. Underlying the relation between clusters and innovation is the assumption that 
co-located firms engaged in innovative activities benefit from knowledge that diffuses 
locally. In order to access this knowledge, firms are often required to form more- or less 
formal relations with co-located firms. Empirical evidence shows however that besides some 
success cases like Silicon Valley and the Emilia- Romagna region where firms collaborate 
intensively, many regional clusters are mere co-locations of firms. To enhance our 
understanding of why some clusters become networks of strategic collaboration and others 
don’t, we study link formation within European biopharmaceutical clusters. More specifically 
we look at the effect of cluster characteristics such as number of start-up firms, established 
firms or academic institutions, or the nature of the collaborations on the probability of local 
link formation 
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 1 Introduction 
Regional innovation, local knowledge spill-over and cluster synergy are concepts that have 
long spurred policy makers to invest heavily in the co-location of firms such as technology- 
and science parks. These investments however rely on two assumptions: one is that there is 
some sort of knowledge diffusion process going on among co-located organizations that is 
beneficial to these organizations, and the other is that this knowledge diffusion occurs in 
geographically confined areas. These assumptions are supported by empirical and theoretical 
evidence where high-tech clusters with strongly connected organizations are recognized as 
engines of national economic performance (Storper, 1995; Scott, 1993; Saxenian, 1994). 
While there are examples of highly innovative regions where firms exchange knowledge 
intensively, there are many more regions where co-location does not induce any knowledge 
exchange.  
As the exchange of knowledge is considered crucial for innovation in science based 
industries, this paper aims to bring to light what determines knowledge exchange in clusters 
of co-located firms. More specifically, we exploit empirical data from the European 
pharmaceutical industry, as it is the most science based industry today and we focus on one 
particular form of knowledge exchange, namely formal collaborations. 
Knowledge can diffuse through various routes, depending among others on the type of 
knowledge that is diffused (e.g. whether it concerns tacit or codified information or whether it 
is appropriable) and on the type or organizations involved. Knowledge diffusion can take the 
form of informal personal interactions, formal collaborations, spin-out companies and 
consultancy or through job mobility (Abramovsky et al, 2007). In this study we look at 
formal collaborations as a means of knowledge diffusion. Firms in technology intensive 
environments transfer valuable knowledge through formal interactions rather than through 
informal social contacts (Zaheer and George, 2004). Moreover, we argue that while informal 
knowledge exchange can play an important role in innovation, it often travels along more 
formal interactions such as lunch meetings, or other social occasions with formal alliance 
partners. Especially in our empirical setting, which is the pharmaceutical industry, formal 
collaborations have shown to be crucial in the organization of innovative labor and in the 
acquisition of new skills and technologies (Hagedoorn, 2002; Owen-Smith et al, 2002). 
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Given the importance of formal collaborations, the question is: when do these collaborations 
require geographical proximity? While there is convincing evidence of the existence of 
geographically mediated knowledge diffusion in science driven industries (see Audretch & 
Feldman, 1996; Jaffe, 1989; Prevezer, 1997), less is known about what drives this 
geographically mediated knowledge diffusion or, as in our case, local collaboration. From a 
policy maker’s perspective, for whom geographical proximity is given, one should turn this 
question around by asking: when do co-located organizations collaborate? 
In the existing literature on firm innovation in relation to locational decision, emphasis is 
mainly on why firms cluster geographically. One important finding is that geographically 
mediated knowledge spillovers can partly explain the geographical clustering of innovative 
firms. While studies emanating from US data indeed show that innovative tacit knowledge 
transfers locally through formal alliances (Zucker et al, 1996), little is known about the 
European situation. Our study not only reveals partly contradicting evidence, but also 
indicates factors that do induce local link formation in European clusters. Proposed 
explanatory factors from the literature that we include in our analysis are: type of 
organizations present, relational embeddedness, nature of knowledge that is exchanged, 
technological diversity, and life-cycle effects. 
 
The empirical setting of this paper is the European biopharmaceutical industry. The 
biopharmaceutical industry appears to be a very appropriate setting to test our research 
questions since it is not only a highly innovative science based industry, but firms active in 
biopharmaceuticals tend to cluster geographically (Swann & Prevezer, 1996; Zaheer & 
George, 2004; Zucker, 1996). Thereby, due to the specific characteristics of drug 
development, such as high commercial values and natural excludability, the number of 
strategic collaborations is high (Hagedoorn, 2002). With rare exceptions, existing studies on 
innovative clusters are case studies of one or two regional clusters and existing quantitative 
studies are mostly based on data from the United States. Our paper distinguishes itself from 
these existing studies by covering 100 European clusters of deal active firms and fairly 
detailed information per cluster, such as type of organizations, type of alliances (R&D 
collaboration, licensing etc) and the therapeutic focus of alliances. Furthermore the time span 
of our data (1996-2005) allows us to first provide a preliminary longitudinal view of 
collaboration activity in Europe and finally to create clusters of firms in which alliance 
activity is based on realistic assumptions of alliance duration. Lastly, our use of longitudinal 
data enables us to significantly reduce endogeneity problems. In what follows we propose 
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hypothesis based on our discussion of the literature on innovation, collaboration and 
geographical proximity (section 3). Section 4 of the paper will discuss the data and research 
methodology, followed by the results in section 5. In the concluding section (section 6) of the 
paper we will discuss the results, its implications and limitations and give some directions for 
future research. We will start with a preliminary view on the data (section 2). 
 
2 Preliminary data view 
In figure 1 we have plotted the amount of annual newly announced agreements between 
organizations in the European pharmaceutical industry. We distinguish between local 
agreements and non-local agreements. Local agreements are agreements between 
organizations located in the same geographical cluster and non-local agreements are 
agreements between organizations that are not located in the same cluster. We further define 
a cluster as a group of co-located organizations. The boundaries of our clusters are chosen in 
such a way that the geographical distance between organizations within our clusters is 
minimized while maximizing the distance between clusters. More details about the boundary 
setting of our clusters are given in section 4. Agreements, hereafter referred to as linkages, 
are formed at all phases in the production process of drug development, ranging from early 
stage drug discovery collaborations to marketing and distribution agreements. 
 
 
From 1996 till 2005 we can clearly distinguish 3 waves of link formation, with peaks in 1998, 
2001 and 2004 respectively. While local linkages and non-local linkages seem to follow the 
same pattern in link formation, the absolute number of linkages that occur locally is much 
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lower compared to non-local linkages.  To identify the whole network of collaborations at 
various moments in time we created ‘snapshots’ of the network of collaborations in June 
1999, June 2002 and in June 2005. These ‘snapshots’ build on the assumption of alliance 
duration of 3 years (Phelps, 2003), which means that each ‘snapshot’ captures all new 
agreements announced back to three years before taking the ‘snapshot’. In table 1 and figures 
2, 3 we show these snapshots of the European pharmaceutical industry. We are aware that our 
dataset is limited in the sense that we do not observe firms which have not formed alliances 
for three years. However, we do not consider this a major problem since competitive firms in 
the pharmaceutical industry are almost always deal-active (Arora & Gambardella, 1990). 
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European pharmaceutical clusters are increasing in size with mean cluster sizes almost 
doubling from 1999 until 2005. In the same period we see a growing dominance of London in 
figure 2 as the largest pharmaceutical cluster in terms of deal-active organizations present. 
This visual observation is confirmed as a general trend of increasing inequality in the 
distribution of organizations over European clusters (standard deviation of organizations per 
cluster more than doubles from 1999 until 2005). 
 When we look at the evolution of alliance activity of the organizations in these clusters in 
table 1 and Figure 3, it is no surprise that alongside the increasing number of deal-active 
organizations, the number of alliances has increased as well. 
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In figure three, the size of the nodes represent the intensity of local collaboration (within 
clusters) and the ties between nodes reflect the intensity of non-local collaboration. Two 
observations are worth mentioning here. One is that while Milan was in 1999 clearly the 
European centre of collaboration activities, London has gained dominance in 2002 and even 
reinforced its position in 2005. While this shift from Milan to London is apparent in the 
alliance network, this is not the case in the geographical landscape of figure 2. This indicates 
that the regional clusters dominating the European landscape in terms of size (representing 
the number of firms) does not necessarily imply that these clusters are also central in terms of 
connectivity. A second observation is that it seems at all moments in time, that local link 
formation and non- local link formation are complements and not substitutes (the largest 
nodes in figure 3 are also the most connected nodes). This observation might hint at the 
potential of combining visions of clusters as regional growth engines through local 
collaboration (Storper, 1995; Scott, 1993) with views of clusters as competitive hubs in 
global networks through international collaboration (Porter, 1990; Batheld et al., 2002). 
Although our study focusses on explaining local link formation, this preliminary data view 
informs us of the importance to regard local link formation in relation to link formation in 
general or to ‘international’ link formation more specifically. 
 
 
3 Literature & Hypotheses 
The literature on local knowledge transfer through strategic collaborations is divided into 
studies emanating from economic geography and management studies focusing on strategic 
technology partnering. Within economic geography, local knowledge transfer is mainly 
analyzed as one reason why firms co-locate. Strategic collaboration has in this view been 
analyzed as an important route through which knowledge is transferred locally. From the 
perspective of management studies the emphasis is on strategic collaborations and partner 
choice, whereby geographical clusters are merely considered as a potential place to meet. 
Because interesting empirical contributions to our research question originate from both 
disciplines, we aim to integrate the findings under the heading of link formation and local 
link formation more specifically. 
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Link formation 
The main argument for the formation of inter-firm linkages has been that it provides firms in 
innovation-driven industries access to new knowledge (Mowery, 1996). Especially in the 
pharmaceutical industry there is an abundance of empirical evidence of the increasing 
importance of inter-firm alliances as a way to acquire knowledge that is crucial for innovation 
(Hagedoorn, 2002; Owen-Smith et al, 2002). 
Other reasons for link formation that have been advocated are efficiency reasons (risk & cost 
sharing, mutual specialization and consolidation of production capacity) and strategic reasons 
such as the improvement of the firm’s long-term product market position. A relatively new 
argument in management studies originating from sociology is the embeddedness perspective 
on the understanding of inter-firm link formation. From the relational embeddedness 
perspective collaborations between organizations are more likely to occur when they are 
embedded in previous relations. Relational embeddedness creates trust and transparency 
among organizations which in turn increases learning performances and reduces costs of 
mitigating opportunistic behavior (Gulati, 1998; Wuyts, 2003). 
With these theoretical perspectives in mind, we now turn our attention to the influence of 
geography on the process of link formation. In other words, how does ‘being in the 
neighborhood’ affect the above described reasons for strategic collaboration? Furthermore, 
related to the question of why organizations collaborate is the question of when to expect 
local collaboration. To answer these questions we build on insights from economic 
geography, where geographical proximity between organizations and the effect on knowledge 
flows has been studied intensively. 
 
 
Local link formation 
3.1 The nature of knowledge 
The competence based view of the firm argues that geographical proximity is beneficial for 
firms in the process of mutual knowledge acquisition. The reason for this is that geographical 
proximity offers the possibility of face-to-face contact which in turn facilitates the 
transmission of highly specified knowledge (Lundvall, 1992; Saxenian, 1994). Highly 
specified knowledge (as opposed to codified knowledge) is often embedded in routines, 
peoples and in machines, and therefore its transfer is geographically bounded (Nonaka, 1994; 
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Blanc & Sierra, 1999; Jaffe & Trajtenberg 1993; Zucker, 1996). In sum, the competence 
based view proposes that access to specific knowledge can be regarded as a reason for 
organizations to form local collaborations. From a transaction cost perspective of the firm, 
there exists however a danger in inter-organizational knowledge flows, that is, unintended 
knowledge flows easier within geographical proximity and can result in opportunistic 
behavior (Narula & Santangelo, 2005). From this point of view, knowledge that diffuses as a 
non-excludible public good (e.g. urbanization economies) can explain the geographical 
clustering of firms since it reduces transaction costs, but it does not explain local link 
formation. Taking these arguments together we expect local link formation to occur only 
when knowledge is excludable (through patents or naturally) and commercially valuable. 
Furthermore, the expectation of local link formation should according to Rallet and Torre 
(2000) be refined, since the requirement of geographical proximity might be temporary and 
does not always necessitate co-location. These authors argue that as the nature of the 
collaboration between organizations moves from exploration of potential new products or 
technologies to the exploitation of the product or technology, tasks of organizations involved 
become more routinized and the need for geographical proximity decreases. The notion that 
the proximity requirement depends on the nature of activities and phase of the product life 
cycle is in line with Saxenian’s finding in Silicon Valley, where mainly small and medium 
sized firms explore niche markets and are at the forefront of new knowledge which is still 
non- routinized. Thus, one can say that as far as explorative and exploitative activities in new 
product development are undertaken by separate organizations, the organizations involved in 
exploration are expected to be co-located in the same cluster. 
In the pharmaceutical industry, the production process of new drug development is roughly 
divided into explorative or upstream activities aimed at the discovery of new drugs and into 
exploitative or downstream activities aimed at the development, marketing & distribution of 
drugs (Powel, 1996; Liebeskind et al, 1996). Existing empirical studies have mainly focused 
on the organization of upstream activities, since here, naturally excludable and highly 
specified knowledge is transferred between organizations through formal alliances. 
Furthermore, it has been shown that in the US at least, these collaborations are formed 
between co-located organizations (first academic and start-ups firms, later established firms), 
indicating the importance of geographical proximity for knowledge transfer (Zucker et al, 
2002). We now can formulate our first hypothesis as follows: 
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Hypothesis 1. Clusters with many upstream alliance activities (focusing on exploration) have 
a higher probability of local collaboration 
 
3.2 Technological proximity 
While the above posed hypothesis is founded in an abundance of existing empirical evidence, 
there is a recent and growing literature in management- and innovation studies that seems to 
argue otherwise. In these latter studies, partner selection (or link formation) is the main 
dependent variable that one seeks to explain and geographical proximity is placed next to 
technological proximity and relational proximity as potential explanatory variables for the 
formation of a formal alliance (Gulati, 1995; Sorenson & Stuart, 2002). It is argued that in 
order for firms to effectively collaborate, learn and apply the resulting knowledge in the 
organization, it is necessary to have a certain minimum level of technological proximity 
(Wuyts, 2003). Technological (also referred to as cognitive) proximity indicates a common 
‘mental’ framework that cannot be obtained simply through intensive interaction, but requires 
training and education in the same specific knowledge domains. Given a minimum amount of 
technological proximity, it is the complementarities or variety in the knowledge bases of both 
firms that induces the highest and most effective knowledge spillovers. Organizations that are 
after these knowledge spillovers will collaborate with partners in any geographical location, 
and they will more likely use their network of social relations or some professional occasion 
(such as a conference) to connect to these potential partners. While collaboration between 
organizations might sometimes be within a regional cluster, it is the technological proximity 
that drives the relation rather than geographical proximity (Breschi & Lissoni, 2001). 
Regional innovative clusters such as Silicon Valley or the Boston cluster (around MIT & 
Harvard) are examples of this latter phenomenon.  
 
When we translate the notion of technological proximity between firms back to the level of a 
regional cluster, we find that it coincides with both the notion of ‘flexible specialization’ 
(Piore & Sabel, 1984) in a cluster and with the notion of ‘related variety’ (Frenken, 2007). 
‘Specialization’ and ‘variety’ (diversity) represent two opposing views in the economic 
geography literature as the answer to what induces regional knowledge spillovers. In the 
literature these are referred to as MAR externalities versus Jacobs’s externalities respectively 
(see Autant-Bernard (2006) for a discussion). By conceptually distinguishing diversity as 
related-, and unrelated variety (Frenken, 2007) these two (seemingly opposing) views come 
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together. ‘Specialization’ refers to the relatedness or the similarity of technologies and 
‘flexible’ refers to the benefits that accrue to co-located firms from the complementarities or 
variety in related activities. Both concepts ‘flexible specialization’ and ‘related variety’ 
basically argue that knowledge spills over between organizations which are involved in 
complementary activities with minimum technological proximity. The main difference 
between both concepts lies in the level of sectoral aggregation at which knowledge spillovers 
are assumed to occur. While the ‘flexible specialization’ thesis focuses on complementarities 
within an industry, ‘related variety’ is focused on inter-sectoral complementarities. As we 
will come to see in the data section of this paper, we propose to let go of any assumptions 
about the appropriate aggregation level at which spillovers occur and simply test whether 
complementarities pay-off in terms of local collaboration.  
 
From the above literature discussion we can conclude that being co-located does not in itself 
provide incentives for collaboration. However, if firms in a cluster are active in a variety of 
related activities, we expect to see an increased probability to collaborate. Hence our second 
hypothesis: 
 
Hypothesis 2. Clusters with a high variety in related technological / knowledge domains have 
a higher probability of local collaboration. 
 
3.3 The type of organizations present 
The theory of neo-Marshallian districts states that regional collaborations take place mainly 
between small firms that are specialized in different parts of the production process of similar 
products. The smallness of the firms in these districts is perceived essential in order to 
provide mutual interdependence and trust (Markusen, 1996; Simmie & Sennet, 1999). While 
not related to a neo-Marshallian district, Saxenian (1991) also finds a more practical reason 
why small and medium sized firms are more likely to collaborate locally. Start-up firms often 
collaborate locally in science driven clusters because they are university spin-offs, whose 
founders stay close to university because of dual occupations. This leads us to a third 
hypothesis regarding when to expect local collaboration 
 
Hypothesis 3. Clusters with relatively many start-up firms have a higher probability of local 
collaboration. 
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 The work of Zucker et al (1996) has shown that biotechnology star-scientists at universities 
are rather entrepreneurial and are responsible for local alliances between the university and 
local private firms. While for US data there is convincing evidence of cluster formation 
around academic organizations, there is still very little insight in whether European academic 
organizations have the same effect. Our fourth hypothesis can therefore be stated as follows: 
 
Hypothesis 4: clusters where relatively many academic institutions are located have a higher 
probability of local collaboration. 
 
3.4 (cluster) Life cycle effects 
The above literature suggests that local collaboration is more likely to occur when academic 
and start-up organizations are co-located. However, it might be the case that when too many 
collaborating organizations are co-located, the information that is exchanged becomes 
redundant. This, in turn, may reduce the incentives for firms to form new collaborations. 
Evidence of such decreasing returns is provided by Fingleton et al (2005) in their study on the 
effect of geographical clustering on high technology SMEs in the computing industry. While 
sector specific, the commonality of characteristics between computing and 
biopharmaceuticals, such as being technology and innovation intensive, with rapid growth 
and the crucial role of SMEs (Fingleton et al, 2005) has been confirmed in the study on 
cluster evolution by Swann & Prevezer (1996). While redundancy is certainly a plausible 
explanation for decreasing returns to local collaboration, we will also investigate a second 
explanation for decreasing returns. It might be the case that as clusters increase in terms of 
number of organizations, their function changes from providing organizations local ‘support’ 
collaborations to being a hub from where organizations connect internationally. In this latter 
situation, decreasing returns to local link formation should be accompanied by increasing 
returns to non-local link formation. Or, to put it differently, clusters that grow large enough 
become (reaching a certain threshold) visible in the global network, which helps 
organizations to go ‘international’. We will test whether a growing number of deal-active 
organizations in a cluster cause decreasing returns to the propensity to collaborate locally. 
Additionally, we will investigate whether a decreasing tendency to collaborate locally is 
complemented by an increasing probability to collaborate non-locally. 
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Hypothesis 5. We expect to find an inversed u-shaped relation between the number of deal 
active organizations and the probability to collaborate locally. This relation would indicate 
decreasing returns of local collaboration. 
 
4 Data and methods 
 
4.1 Data 
We used the Pharmadeals database which globally monitors the announcement of a variety of 
strategic alliances in the biopharmaceutical industry on a daily basis since 1996. The data 
preparation has been a three stage process. 
 
To start with, we selected alliances where at least one European partner was involved. The 
database did not at that time allow us to create a query based on the location of organizations, 
and we used European countries as keywords to search for a match in any part of the alliance 
announcement (including press release). This resulted in a hit of 2800 alliances between June 
1996 and June 2005.  
In a second stage we have split alliances where multiple partners were involved. Of these 
2800 alliances, some 300 appeared to involve more than 2 separate organizations. We 
decided to split those alliances into each possible combination of alliances. Thus, an 
agreement with n participating organizations was transformed into n x (n-1)/2 linkages. 
Hence, we assume that an alliance serves as a conduit of knowledge transfer, where 
information transfers between all participants in an alliance (whether the alliance is a R&D 
collaboration between multiple universities or a project of some pharmaceutical companies 
who received EU funding). Turning all these multiple partner alliances into dyads led to a 
new alliance set of 4031 alliances among 2500 separate organizations. 
Thirdly we manually looked up the cities where organizations are located and found around 
650 organizations either not tractable or undisclosed by Pharmadeals or being a USA based 
firm with a USA based partner (this latter phenomenon can be explained by the splitting of 
multiple partner projects).  
Our final work set consisted of 2566 alliances among 1834 organizations of which 1054 are 
organizations located in Europe. We geo-coded each organizations’ location and used a 
hierarchal clustering algorithm based on Euclidian distances between locations to define 54 
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European clusters. Since we are interested in local collaboration we define a cluster as a 
geographic area where at least 2 deal- active organizations are located. Having identified the 
European clusters we aggregated the information on organizations and their alliances back to 
the regional clusters. Table 2 summarizes the terminology and definitions of our clusters.   
 
 
Finally we have created three ‘snapshots’ of our clusters over time. Following an extensive 
study by Phelps (2003) on the duration of alliances, the most realistic assumption of alliance 
duration is three years. The assumption of three year alliance duration is however an average. 
While our data enable us to distinguishing different alliance types, we found no information 
on average alliance duration per alliance type. Based on three year alliance duration we have 
created the following cluster snapshots: 
• European clusters at t1 = based on the alliances announced between June 1996 and 
May 1999. 
• European clusters at t2 = based on the alliances announced between June 1999 and 
May 2002. 
• European clusters at t3 = based on the alliances announced between June 2002 and 
May 2005. 
In order to increase our observations we pooled the observations of our explanatory variables 
of t1 and t2 and our observations of the dependent variable of t2 and t3 respectively. We 
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performed a Wald test to make sure there is significant variation between the information 
provided by the recurring clusters, so as to treat them as independent observations. This 
increases our number of observations to 108, as shown in the descriptive statistics (table 3) 
below. 
 
 
4.2 Dependent variable 
As our aim in this paper is to explain the determinants of collaboration within a geographical 
cluster, our dependent variable is intra-cluster collaboration (Local_coll_Y). Intra-cluster 
collaboration is measured as the number of alliances where both partners are located inside 
the cluster. While this measure captures only formal alliances that are publicly announced, 
we argue, following Zaheer and George (2004) that firms in technology intensive 
environments can only transfer valuable knowledge through formal interactions and not 
through mere physical presence in a cluster or through informal social contacts. We also 
argue that possible knowledge spillovers or more informal interaction travels along these 
formal alliances (during lunch meetings, dinners or other occasions with alliance partners). In 
order to minimize reversed causality we lagged the dependent variable. 
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 4.3 Independent variables 
Control variables 
Local collaboration at t-1 (Intraclusx). While the issue of reversed causality has been taken 
into consideration through the lagging of the dependent variable, network studies show that 
there is another danger, which is autocorrelation. Within the network literature there is 
general agreement that new alliance formation is a path-dependent process, where firms are 
likely to partner with previous partners or with partners of previous partners (Gulati, 1995; 
Coleman, 1988; Granovetter, 1985). Given this feature of alliance behavior, lagging a 
dependent variable doesn’t completely solve the issue of causality, because local 
collaboration at time t can be driven completely by its local collaborations at time t-1 which 
could in turn drive our explanatory variables. In order to control for this effect we inserted the 
number of local collaborations at time t-1 (intraclusX) as control variable. 
 
Cluster size (Nodes). We controlled for size effects of clusters by counting the number of 
deal-active organizations. 
 
Explanatory variables 
Start-up. Number of deal-active start-up firms located in a cluster 
Financial. Number of deal-active financial firms located in a cluster 
Established. Number of deal-active established firms located in a cluster 
Academic. Number of deal-active academic organizations located in a cluster 
Upstream alliances (Linksup).With this variable we aim to capture explorative knowledge 
transfer (including highly specified knowledge). For each cluster we have counted the 
number of alliances aimed at drug discovery or R&D. We further included alliances that 
involved academic organizations, and alliances that were funded by the government (as basic 
science collaborations often are). 
Downstream alliances (linksdown). With this variable we aim to capture exploitative 
knowledge transfer (including codified knowledge). For each cluster we have counted 
alliances that where active in marketing, distribution, manufacturing & supply or in co-
promotion activities. 
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(Related) variety. In our second hypothesis we proposed that clusters in which there is a 
higher variety of related technological- or knowledge domains, we expect a higher 
probability of local collaboration. Since the information of our clusters is build upon alliance 
information and not upon organizational information, we have to rely on a proxy for 
technological proximity. We used the therapeutic focus of an alliance formed by 
organizations located in a cluster as if it were an organizational characteristic. Our 
justification for this strategy is that organizations can only collaborate in a therapeutic area 
where they are knowledgeable. We are however aware of the misinterpretation

 danger of this 
measure, since organizations could also collaborate in knowledge domains which are 
complementary to them. Support for our approach can be found in the relational view of the 
firm, which states that a firms’ portfolio of alliances can be regarded as an important resource 
of the firm and a major source of competitive advantage (Dyer & Singh, 1998). Following a 
number of previous studies that aim to measure technological proximity or related variety in a 
geographic area, we calculated the degree of entropy of each cluster (Frenken 2007; Boschma 
& Iammarino 2007). While Boschma & Iammarino (2007) further specify their definition of 
variety to capture related variety, we can measure related variety using their variety measure. 
The reason for this is that our data are based on alliance information which by definition 
already ensures relatedness. Furthermore, alliances are aimed at fulfilling a part of the drug 
development process, which implies some degree of technological or cognitive proximity. 
Variety within these activities is caused by linkages focusing on different therapeutical areas 
and even on technologies originating from different sectors such as informatics (e.g. 
bioinformatics), or mechanical engineering (e.g. medical devices). Formally we measure 
(related) variety as entropy which we define as: 
 
 
Variety = ∑
= ⎟
⎟
⎠
⎞
⎜⎜⎝
⎛N
i i
i p
p
1
2
1log  
 
pi represents the share of linkages formed in therapeutic area i, with i ranging from 1 to N in 
each cluster. As the range of therapeutic areas in a cluster is partly driven by the size of a 
cluster, we weighted our clusters by size. Variety thus measures the weighted sum of 
therapeutical areas in which organizations are deal-active whereby therapeutical areas with 
relatively fewer linkages are weighted stronger.  
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 Nodes & Squared nodes. Measuring the effect of cluster size (nodes) and the squared cluster 
size (squared nodes) on local link formation enables us to see whether there are decreasing 
returns to local collaboration. The interpretation of decreasing returns to link formation can 
be twofold: First, it might be that the cluster has become so crowded with interacting 
organizations that the information they transfer has become redundant. Second, the number of 
organizations in a cluster may increase up to a point where the cluster becomes 
‘internationally visible’ and, as a result, induce firms to collaborate internationally instead of 
locally. If the latter scenario holds, we expect to see decreasing returns to local link formation 
in combination with increasing returns to non-local link formation. Variables that were 
distributed non-normally have been transformed to logarithms. 
 
Non-local linkages. While our aim is to understand what causes local link formation, there 
are two reasons to take non-local link formation into account. First, if we want to be sure that 
factors which we find to induce local link formation are specifically local or whether these 
factors induce link formation in general, we need to compare the effect of our predictors on 
local and on non-local link formation. Second, as we have seen from our preliminary data 
view, regional clusters may perform a dual role in an economy, namely they may be locally 
embedded and at the same time function as nodes in a global network. While the 
investigation of this dual role is beyond the scope of this paper, it would be naive to confine 
our view on inter-firm collaborations to local collaborations, especially given the global 
scope of the pharmaceutical industry. 
 
4.4 Analysis 
We test our hypotheses using negative binomial regressions. While Poisson models are often 
used with count data, these models require the mean to be equal to the standard deviation. As 
the descriptive statistics in table 3 show, this latter requirement is not fulfilled in our 
dependent variable. As our dependent variable contains a high number of zero values 
(indicating that no local collaboration takes place), we performed a Vuong test to see whether 
using a zero-inflated negative binomial regression model would better fit our data. This was 
not the case. 
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5 Results 
Table 4 shows the regression results, which are presented separately for each hypothesis. 
 
 
5.1 The nature of knowledge 
The first set of variables relate to our hypothesis that upstream alliance activity which entails 
the exchange of highly uncertain and specified knowledge (such as drug discovery) is 
positively related to local link formation. To see whether this relation is specific to upstream 
alliance activity, we compared the effects of upstream alliance activity to the effects of 
downstream alliance activity. Further we tested whether our hypothesized effects are specific 
to local link formation by comparing the effects of each of our explanatory variables on local 
link formation with their effect on non-local link formation. Our findings lead us to reject our 
 
21
1st hypothesis indicating that upstream, explorative knowledge exchange does not have a 
significant effect on local link formation. However, we do find that upstream knowledge 
exchange strongly and positively (z = 12.81) predicts expected non-local link formation. This 
result seems to indicate that valuable and highly specified knowledge is sourced from any 
location. However, we have to be very careful since not only upstream alliance activity but 
also downstream alliance activity is positively correlated with non-local link formation. 
 
5.2 related variety 
Our second hypothesis stated that clusters with a higher variety in related technologies 
(therapeutic areas) have a higher probability of local link formation. The more variety in a 
cluster, the higher the potential knowledge spillovers and learning effects would be. While 
we found no significant effect of variety on local link formation for the whole sample, we 
found a positive and significant effect of variety for relatively small clusters. We 
distinguished between variety effects in small clusters and large clusters by adding an 
interaction variable between variety and cluster size. The positive effect of variety in smaller 
clusters is in line with the intuition that small clusters provide organizations with local 
support while large clusters function as global hubs. Local support in these clusters could be 
provided through inter-organizational collaboration if these organizations’ activities are of a 
complementary nature (indicating a high variety). Further support for the above described 
intuition arises when we take a look at the effect of variety on non-local link formation. 
Variety has a negative significant effect on non-local link formation. This means that in 
clusters where activities are more specialized (less variety), there is more ‘international’ 
(non-local) link formation. Again, the intuition seems in place that clusters which function as 
global hubs, search for complementary knowledge through ‘international’ alliances and do 
not benefit from a local variety of knowledge or technologies. In sum, we can say that in 
small clusters firms form more local ‘support’ collaborations when there is more 
therapeutical variety. When firms in a cluster are active in similar therapeutic areas 
(specialization) they are capable of forming more non-local or international collaborations.  
 
5.3 type of organizations present 
Hypotheses 3 and 4 relate to the type of organizations present and whether or not to expect 
local link formation from their presence. Table 4 shows the estimated effects of academic 
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organizations, start-ups firms and established pharmaceutical firms on local link formation. 
Financial organizations are treated as a reference category. Academic organizations are the 
least strong drivers of local collaborations, while they are the strongest drivers of non-local 
(‘international’) linkages. This finding leads us to reject hypothesis 3, which stated that 
academic organizations collaborate locally. This result is in line with our previous finding 
that explorative activities, which are often carried out by academic organizations, are non- 
local. Our fourth hypothesis, regarding the positive effect of startup firms can be confirmed. 
Startups are more likely to collaborate locally and local collaborations are more likely to 
occur than non-local collaborations. Finally, while we did not hypothesize on the effect of 
established firms based on previous literature, established firms do perform an interesting 
role in link formation. While academic organizations mainly induce non-local collaborations 
and startups are more likely to collaborate locally, established firms are the drivers of both 
local and non-local linkages. In other words, established firms can be said to exert a bridge 
function in connecting a cluster locally and ‘internationally’. 
 
5.4 cluster life cycle 
Our last hypothesis (5) deals with the issue of the life cycle of a cluster. The assumption in 
the literature is that as the number of active organizations in a cluster grows, there will be 
decreasing returns to local link formation. We proposed two testable views to explain this 
phenomenon. One is that congestion effects occur because the information exchanged 
through collaborations is becoming more and more redundant as the cluster grows. A second 
scenario we investigated is one where larger clusters are more globally ‘visible’, enabling 
firms to collaborate non-locally rather than locally. If this latter scenario is indeed true, we 
expect to find increasing returns to non-local link formation. Based on our findings in table 4 
we confirm decreasing returns to local link formation, but reject increasing returns to non-
local link formation3. We interpret this finding as evidence of local congestion effects. In 
other words, as the number of organizations in a cluster grows, the number of new 
collaborations, both local and non-local, decreases.  
 
                                                 
3 Decreasing returns to local link formation is indicated through a switching coefficient (positive to negative) for 
nodes and squared nodes respectively. A simple scatter plot (appendix I) shows that the probability to 
collaborate locally does not become negative within our range of organizations. 
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VI Discussion & conclusion 
The primary aim of this paper was to help policy makers understand why some regional 
clusters are networks of intense collaboration while most clusters are mere co-located firms. 
Behind this aim lies an extensive literature that claims these networks of intense collaboration 
are a crucial factor for the innovative performance of firms that make up these clusters. Our 
findings suggest that indeed only very few regional clusters can be described as networks of 
intense collaboration. However, this skew distribution of linkages over clusters is not specific 
to local link formation but characterizes alliance activity in general. In other words, there are 
some clusters that are networks of internal collaboration which are at the same time important 
hubs in non-local networks, while most clusters are merely co-located firms. Moreover, most 
other cluster characteristics that we investigated are also skewly distributed which indicates 
the high diversity of European pharmaceutical clusters. This might explain the prevalence of 
case studies in this area focusing on one or two specific clusters. 
There are two main lessons that policy makers can take from our analysis. The first lesson is 
a rejection of the most common ideas about when to expect local link formation, and the 
second contains some clear evidence of factors that do induce knowledge exchange through 
local collaboration. 
First, it is rather striking and counterintuitive that whereas in the US highly specified 
explorative knowledge spills over from universities into US clusters through formal 
collaborations, in Europe this appears not to be the case. Instead, explorative R&D activities 
such as early stage drug discovery induce non-local alliance formation. This finding is in line 
with what Adams and Jaffe already found in 1996, namely that pharmaceutical R&D 
spillovers do not decrease as much with distance as other industries’ R&D does. One reason 
for the non-stickiness of pharmaceutical R&D in Europe could be that research centers and 
start-ups with ‘forefront’ knowledge are located in the US, thus making global link formation 
more important than local link formation for acquiring access to valuable new knowledge. To 
see whether alliance activity with US partners functions as a substitute for local knowledge 
transfer, we briefly tested the effect of ‘USA connectivity’ (number of alliances of firms in a 
cluster with US partners) on local link formation (see table 4). As the table shows, there is no 
significant effect of USA connectivity on local link formation, and hence we can not speak of 
a substitution effect between knowledge sourcing from the US and local knowledge 
spillovers (through alliances) in Europe. 
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Second, we found clear positive effects of (related) variety in small clusters, of start-up firms 
and of established pharmaceuticals on local knowledge exchange. These findings support a 
resource based view on strategic alliances, where local alliances are formed by firms to 
obtain access to complementary knowledge. While clusters are small and contain relatively 
many start-ups firms, resource interdependence outweighs the danger of unintended 
knowledge flows. The danger of unintended knowledge flows, which might increase the 
transaction costs of collaborating, is further mitigated through the technological variety 
amongst the collaborating organizations. The positive effect of variety is however specific for 
local collaboration in relatively small clusters. As we have seen in figure 3, the 
pharmaceutical industry is a truly global industry in which explorative new knowledge is 
mainly sourced non-locally. For policy makers, this implies that clusters can be growth 
engines through local collaborations, but need to be present as hubs in non-local networks as 
well. Our findings suggest that large established pharmaceutical firms are important for 
achieving this dual goal since they induce both local and non-local collaborations.  
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